Mary Fenton

Mary Fenton

Director of Finance/CFO chez CULLINAN THERAPEUTICS, INC.

Fortune : 108 880 $ au 30/04/2024

60 ans
Health Technology
Commercial Services
Consumer Services

Postes actifs de Mary Fenton

SociétésPosteDébutFin
CULLINAN THERAPEUTICS, INC. Comptroller/Controller/Auditor 29/04/2024 -
Director of Finance/CFO 29/04/2024 -
Director/Board Member 06/12/2018 -
Chairman - 06/12/2018

Historique de carrière de Mary Fenton

Anciens postes connus de Mary Fenton

SociétésPosteDébutFin
ONCORUS, INC. Director/Board Member 20/12/2019 27/07/2023
Independent Dir/Board Member 20/12/2019 27/07/2023
VERTEX PHARMACEUTICALS INCORPORATED Corporate Officer/Principal 01/10/2019 01/02/2021
Chief Operating Officer 01/05/2019 01/10/2019
Director of Finance/CFO 01/05/2019 01/10/2019
ACHILLION PHARMACEUTICALS, INC. Comptroller/Controller/Auditor 01/01/2006 28/12/2018
Director of Finance/CFO 01/01/2006 28/12/2018
Investor Relations Contact 01/10/2000 15/08/2018
Corporate Secretary 01/10/2000 01/02/2016
Corporate Officer/Principal 01/08/1991 01/10/2000
TOURMALINE BIO, INC. Chief Executive Officer 26/05/2023 -
Director of Finance/CFO 01/03/2021 -
President 26/05/2023 -

Formation de Mary Fenton

College of the Holy Cross (Massachusetts) Undergraduate Degree
University of Connecticut School of Business Masters Business Admin

Statistiques

Internationale

Etats-Unis 10
Royaume-Uni 2

Opérationnelle

Director of Finance/CFO 4
Comptroller/Controller/Auditor 2
Corporate Officer/Principal 2

Sectorielle

Health Technology 7
Commercial Services 3
Consumer Services 3

Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Sociétés liées

Sociétés cotées3
VERTEX PHARMACEUTICALS INCORPORATED

Health Technology

ONCORUS, INC.

Health Technology

CULLINAN THERAPEUTICS, INC.

Health Technology

Entreprise privées5

Commercial Services

Health Technology

Commercial Services

Health Technology

Health Technology

Voir les connexions sociétés